Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 99,957 | 78,228 | 132,526 | 54,126 | 35,944 |
| Marketable Securities | 421,705 | 213,722 | 250,928 | 257,221 | 136,653 |
| Receivables | 53,046 | 47,530 | 38,000 | 31,658 | 29,937 |
| Inventories | 64,650 | 58,296 | 48,569 | 41,411 | 31,278 |
| TOTAL | $651,623 | $408,557 | $477,969 | $391,110 | $243,089 |
| Non-Current Assets | |||||
| PPE Net | 136,688 | 104,681 | 108,670 | 107,046 | 101,016 |
| Investments And Advances | 95,459 | 75,769 | 40,674 | 74,193 | 0 |
| Intangibles | 196,068 | 203,934 | 62,040 | 55,197 | 46,737 |
| Other Non-Current Assets | 194,675 | 38,124 | 0 | 825 | 624 |
| TOTAL | $622,890 | $422,508 | $211,384 | $237,261 | $148,377 |
| Total Assets | $1,274,513 | $831,065 | $689,353 | $628,371 | $391,466 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,431 | 12,799 | 14,368 | 14,658 | 7,511 |
| Accrued Expenses | 70,974 | 70,427 | 45,865 | 41,057 | 36,666 |
| Other current liabilities | 14,736 | 18,179 | N/A | N/A | N/A |
| TOTAL | $253,328 | $107,673 | $60,661 | $56,217 | $44,838 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 102 | 595 |
| Other Non-Current Liabilities | 401,497 | 368,448 | 307,466 | 292,671 | 127,652 |
| TOTAL | $401,497 | $368,448 | $307,466 | $292,671 | $127,652 |
| Total Liabilities | $654,825 | $476,121 | $368,127 | $348,888 | $172,490 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,863 | 42,033 | 41,230 | 40,712 | 37,525 |
| Common Shares | 44 | 42 | 41 | 41 | 37 |
| Retained earnings | -253,875 | -399,398 | -388,226 | -389,136 | -346,238 |
| Other shareholders' equity | 318 | 322 | -280 | -454 | -30 |
| TOTAL | $619,688 | $354,944 | $321,226 | $279,483 | $218,976 |
| Total Liabilities And Equity | $1,274,513 | $831,065 | $689,353 | $628,371 | $391,466 |